DLG2–DLG4 Expression Is Associated with Improved Survival and a Synaptic Gene Signature in Lower-Grade Glioma
Felipe Gaia, Henrique Ritter Dal-Pizzol, Osvaldo Malafaia, Rafael Roesler, Gustavo R. Isolan · 2026
Read DLG2–DLG4 Expression Is Associated with Improved Survival and a Synaptic Gene Signature in Lower-Grade Glioma by Felipe Gaia, Henrique Ritter Dal-Pizzol, Osvaldo Malafaia, Rafael Roesler, Gustavo R. Isolan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13204321.txt.
Description
Felipe Gaia and co-authors link synaptic scaffold genes to glioma survival in a 2026 study. Brain tumors borrow synapse tricks to grow, yet the tie in lower grade glioma was thin. The team read 36 synaptic genes in tumor data from two atlases.
Three genes, DLG2, DLG3, and DLG4, stood out: higher levels of each tracked with longer survival in both sets. Their levels ran high in oligodendroglioma and IDH mutant tumors and low in astrocytoma and IDH wild type ones. All three rose with a broad synaptic gene program. The marks may help sort patient odds.
Catalog record
| CREATOR | Felipe Gaia, Henrique Ritter Dal-Pizzol, Osvaldo Malafaia, Rafael Roesler, Gustavo R. Isolan |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |